Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?
- Ned Calonge, MD, MPH; and
- Diana Petitti, MD, MPH
- From the Colorado Department of Public Health and Environment, Denver, CO 80246, and Keck School of Medicine, University of Southern California, Los Angeles, CA 90089.
IN RESPONSE:
In making its recommendation on screening for type 2 diabetes, the USPSTF considered interventions, including lipid-lowering agents, for effects on such health outcomes as cardiovascular events. In reviewing the evidence on lipid-lowering agents, the USPSTF found that persons with diabetes do …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
